Deglycosylated antibody specifically binding to clec14a and uses thereof

The present invention relates to a deglycosylated antibody which specifically binds to C-type lectin domain family 14, member A (clec14a), and uses thereof. More specifically, the present invention relates to a deglycosylated antibody which comprises a light chain variable region including CDR1 of a...

Full description

Saved in:
Bibliographic Details
Main Authors Kim, Mi Ra, Lee, Sukmook, Kim, Taek-Keun, Jang, Ji Hye
Format Patent
LanguageEnglish
Published 28.03.2019
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a deglycosylated antibody which specifically binds to C-type lectin domain family 14, member A (clec14a), and uses thereof. More specifically, the present invention relates to a deglycosylated antibody which comprises a light chain variable region including CDR1 of a particular sequence and specifically binds to clec14, and uses thereof, such as a pharmaceutical composition for the prevention or treatment of angiogenesis-related diseases comprising the antibody.
Bibliography:Application Number: AU20170322783